Упрощенная HTML-версия
260.
Endothelial dysfunction: a comprehensive appraisal / R. J. Esper [et al.] //
Cardiovasc. Diabetol. – 2006. - № 5. – P. 4.
261.
Endothelium-dependent vasodilation is related to the fatty acid composition of
serum lipids in healthy subjects / M. Sarabi [et al.] // Atherosclerosis. – 2001. –
Vol. 156, № 2. – Р. 349-355.
262.
Epidemiologic study on factor VII, factor VIII and fibrinogen in an industrial
population. Baseline data on the relation to blood pressure, blood glucose, uric
acid, and lipid fractions / L. Balleisen [et al.] // Thromb. Haemost. – 1985. –
Vol.54. – Р.721-723.
263.
Epidemiology of coagulation factors, inhibitors and activation markers: The
Third Glasgow Monica Survey II. Relationships to cardiovascular risk factors
and prevalent cardiovascular disease / M. Woodward [et al.] // British Journal
of Hematology. – 1997. Vol. 97, № 4. – Р.785-797.
264.
Epidemiology of haematocrit, white cell count, red cell aggregation and
fibrinogen: the Glasgow Monica Study / G. D. Lowe [et al.] // Clin.
Hemorheol. –1992. – Vol.12. – Р.535-544.
265.
Epidemiology of hypertension in Germany. Selected results of population-
representative cross-sectional studies / H.
et al.] // Dtsch. Med.
Wochenschr. – 2006. – Vol. 131, № 46. – Р. 2586-2591.
266.
Esler M. Leptin in human plasma is derived in part from the brain, and cleared
by the kidneys / M. Esler // Lancet. – 1998. – Vol. 351. – P. 879.
267.
European guidelines on cardiovascular disease prevention in clinical practice.
Third Joint Task Force of European and other Societies on Cardiovascular
Disease Prevention in Clinical Practice (constituted by representatives of eight
societies and invited experts). – Eur. Heart J. – 2003. – Vol. 24. – Р. 1601-
1610.
268.
European Society of Hypertension-European Society of Cardiology guidelines
for the management of arterial hypertension-2003 //